- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1528-3658
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
SARS-CoV-2 and interferon blockade ; volume:26 ; number:1 ; day:9 ; month:11 ; year:2020 ; pages:1-6 ; date:12.2020
Molecular medicine ; 26, Heft 1 (9.11.2020), 1-6, 12.2020
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s10020-020-00231-w
- URN
-
urn:nbn:de:101:1-2020122022275833302380
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Diamond, Betty
- Volpe, Bruce T.
- VanPatten, Sonya
- Al Abed, Yousef
- SpringerLink (Online service)
Other Objects (12)
Interferon Treatments for SARS-CoV-2: Challenges and Opportunities
Interferon antagonists encoded by SARS-CoV-2 at a glance
Monocyte‐crosstalk drives interferon‐mediated signaling following SARS‐CoV ‐2 exposure
Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Role of interferon gamma in SARS-CoV-2-positive patients with parasitic infections
Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
SARS-CoV-2-Arbeitsschutzstandard
Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
Interferon‐induced transmembrane protein 3 (IFITM3) limits lethality of SARS‐CoV‐2 in mice
Interferon Treatments for SARS-CoV-2: Challenges and Opportunities
Interferon antagonists encoded by SARS-CoV-2 at a glance
Monocyte‐crosstalk drives interferon‐mediated signaling following SARS‐CoV ‐2 exposure
Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Role of interferon gamma in SARS-CoV-2-positive patients with parasitic infections
Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
SARS-CoV-2-Arbeitsschutzstandard
Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
Interferon‐induced transmembrane protein 3 (IFITM3) limits lethality of SARS‐CoV‐2 in mice
Interferon Treatments for SARS-CoV-2: Challenges and Opportunities
Interferon antagonists encoded by SARS-CoV-2 at a glance
Monocyte‐crosstalk drives interferon‐mediated signaling following SARS‐CoV ‐2 exposure
Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Role of interferon gamma in SARS-CoV-2-positive patients with parasitic infections
Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
SARS-CoV-2-Arbeitsschutzstandard
Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV